|
1 |
Serotonin transporter inhibition and 5-HT2C receptor activation drive loss of cocaine-induced locomotor activation in DAT Val559 mice
Enthalten in Neuropsychopharmacology 21.12.2018: 1-13
|
|
|
|
2 |
IRAK4 degrader in hidradenitis suppurativa and atopic dermatitis: a phase 1 trial
Enthalten in Nature medicine Bd. 29, 13.11.2023, Nr. 12, date:12.2023: 3127-3136
|
|
|
|
3 |
Is dopamine transporter-mediated dopaminergic signaling in the retina a noninvasive biomarker for attention-deficit/ hyperactivity disorder? A study in a novel dopamine transporter variant Val559 transgenic mouse model
Enthalten in Journal of neurodevelopmental disorders Bd. 9, 28.12.2017, Nr. 1, date:12.2017: 1-12
|
|
|
|
4 |
Perseverance’s Scanning Habitable Environments with Raman and Luminescence for Organics and Chemicals (SHERLOC) Investigation
Enthalten in Space science reviews Bd. 217, 25.5.2021, Nr. 4, date:6.2021: 1-115
|
|
|
|
5 |
The SHERLOC Calibration Target on the Mars 2020 Perseverance Rover: Design, Operations, Outreach, and Future Human Exploration Functions
Enthalten in Space science reviews Bd. 218, 22.8.2022, Nr. 6, date:9.2022: 1-33
|
|
Administration
